MBI
ABBV icon

Montrusco Bolton Investments’s AbbVie ABBV Stock Holding History

Montrusco Bolton Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,512
Closed -$894K – 62
2022
Q1 		$894K Sell
5,512
-6,434
-54% -$935K 0.02% 62
2021
Q4 		$1.62M Buy
11,946
+1,781
+18% +$210K 0.04% 61
2021
Q3 		$1.1M Buy
10,165
+4,956
+95% +$566K 0.03% 63
2021
Q2 		$587K Sell
5,209
-17,098
-77% -$1.93M 0.02% 64
2021
Q1 		$2.41M Buy
22,307
+2,369
+12% +$253K 0.08% 61
2020
Q4 		$2.14M Sell
19,938
-15,263
-43% -$1.47M 0.09% 56
2020
Q3 		$3.08M Buy
35,201
+8,327
+31% +$784K 0.16% 55
2020
Q2 		$2.55M Buy
26,874
+21,831
+433% +$1.92M 0.15% 58
2020
Q1 		$384K Buy
5,043
+169
+3% +$14.4K 0.03% 62
2019
Q4 		$432K Hold
4,874
– – 0.02% 61
2019
Q3 		$388K Buy
4,874
+219
+5% +$15K 0.02% 62
2019
Q2 		$339K Sell
4,655
-20,827
-82% -$1.64M 0.02% 63
2019
Q1 		$2.02M Buy
25,482
+19,766
+346% +$1.62M 0.13% 58
2018
Q4 		$527K Sell
5,716
-4,039
-41% -$355K 0.04% 62
2018
Q3 		$923K Sell
9,755
-901
-8% -$85.4K 0.06% 58
2018
Q2 		$987K Sell
10,656
-1,436
-12% -$140K 0.07% 59
2018
Q1 		$1.15M Sell
12,092
-10,394
-46% -$1.14M 0.08% 56
2017
Q4 		$2.17M Buy
22,486
+18,745
+501% +$1.77M 0.12% 59
2017
Q3 		$332K Sell
3,741
-11,030
-75% -$840K 0.02% 66
2017
Q2 		$1.07M Sell
14,771
-3,747
-20% -$252K 0.06% 67
2017
Q1 		$1.21M Sell
18,518
-16,859
-48% -$1.06M 0.07% 64
2016
Q4 		$2.21M Buy
35,377
+8,215
+30% +$501K 0.12% 61
2016
Q3 		$1.71M Buy
27,162
+5,537
+26% +$358K 0.11% 62
2016
Q2 		$1.34M Buy
21,625
+12,865
+147% +$784K 0.09% 66
2016
Q1 		$500K Buy
8,760
+2,135
+32% +$119K 0.04% 74
2015
Q4 		$392K Buy
+6,625
New +$382K 0.03% 65
2015
Q1 		– Sell
-7,000
Closed -$458K – 90
2014
Q4 		$458K Buy
+7,000
New +$441K 0.03% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Montrusco Bolton Investments's ABBV Position: Q2 2022 in Review

Montrusco Bolton Investments sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 5,512 shares — an estimated $894K sold.

Montrusco Bolton Investments first reported a position in ABBV in Q4 2014 and held it in 27 quarters. The position peaked at $3.08M in Q3 2020. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Montrusco Bolton Investments reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • Montrusco Bolton Investments sold 5,512 AbbVie shares in Q2 2022, an estimated $894K.
  • Montrusco Bolton Investments first reported a position in AbbVie in Q4 2014 and held it in 27 quarters.
  • Montrusco Bolton Investments's AbbVie position peaked at $3.08M in Q3 2020.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Montrusco Bolton Investments's 13F filing for Q2 2022, filed 8 Aug 2022.